-
Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons JAMA (IF 55.0) Pub Date : 2017-09-13 Asa Radix, Andrew M. Davis
Transgender individuals have a gender identity that does not align with their sex assignment at birth (gender incongruence). They account for about approximately 0.4% of the US population (1 million people).1 Some transgender people experience gender dysphoria, distress caused by the discrepancy between gender identity and birth-assigned sex, linked to lifetime suicide attempt rates of 40%.2 Some may
-
Incidence and Trends of Sepsis in US Hospitals Using Clinical vs Claims Data, 2009-2014 JAMA (IF 55.0) Pub Date : 2017-09-13 Chanu Rhee, Raymund Dantes, Lauren Epstein, David J. Murphy, Christopher W. Seymour, Theodore J. Iwashyna, Sameer S. Kadri, Derek C. Angus, Robert L. Danner, Anthony E. Fiore, John A. Jernigan, Greg S. Martin, Edward Septimus, David K. Warren, Anita Karcz, Christina Chan, John T. Menchaca, Rui Wang, Susan Gruber, Michael Klompas
-
Counting Sepsis, an Imprecise but Improving Science JAMA (IF 55.0) Pub Date : 2017-09-13 Kristina E. Rudd, Anthony Delaney, Simon Finfer
Sepsis, most succinctly defined as organ dysfunction due to infection, is estimated to account for more than 5 million deaths around the world each year and to cause or contribute to approximately half of all deaths occurring in hospitals in the United States.1,2 A 2016 report from the Healthcare Cost and Utilization Project estimated the cost of treating sepsis in US hospitals in 2013 at $24 billion
-
JAMA JAMA (IF 55.0) Pub Date : 2017-09-12
The JAMA Network is a consortium of peer-reviewed print and online medical publications that includes JAMA® and 11 other specialty Network journals. JAMA does not hold itself responsible for statements made by any contributor. All articles published, including opinion articles, represent the views of the authors and do not reflect the policy of JAMA, the American Medical Association, or the institution
-
-
Progress in Teaching PsychiatryAdolf Meyer, M.D., Baltimore JAMA (IF 55.0) Pub Date : 2017-09-12
The request of our secretary for a contribution to this meeting suggested to me an extension of my discussion1 on the psychobiologic level of medical facts (presented two years ago in San Francisco and published in The Journal of the American Medical Association, 1915), a consideration of my present plan of teaching psychopathology and psychiatry and of some principles characteristic of the plan. No
-
-
-
-
Expanded Tissue Samples Poised to Assist Pathologists JAMA (IF 55.0) Pub Date : 2017-09-12 Jennifer Abbasi
A novel method to physically expand small biopsy tissue samples could help pathologists predict and diagnose disease more accurately using light microscopy. Researchers at the Massachusetts Institute of Technology, Harvard Medical School, and the Broad Institute developed the method, called expansion pathology (ExPath). In ExPath, clinical samples are attached to a polymer that swells when wet. An
-
Lightweight Exosuit Could Help Patients Walk After Stroke JAMA (IF 55.0) Pub Date : 2017-09-12 Jennifer Abbasi
Researchers at Harvard University and Boston University have developed a lightweight, soft robotic exosuit that improves gait in patients who have experienced a stroke. In a small study of 9 patients who ranged from 9 months to more than 14 years poststroke, the exosuit worn on the partially paralyzed lower limb improved forward propulsion and ground clearance during treadmill and overground walking
-
-
-
Medication Reconciliation vs Medication Review—Reply JAMA (IF 55.0) Pub Date : 2017-09-12 Adam J. Rose, Shira H. Fischer, Michael K. Paasche-Orlow
In Reply We agree with Dr Zimmerman and colleagues about the need for a more comprehensive process of medication reconciliation, and there is substantial overlap between the approach we presented in our Viewpoint and the vision they describe. They also emphasize the importance of standardized nomenclature to refer to medication reconciliation, lest a variety of terms for the same concept impede the
-
Behavioral Economics and Health Insurance Reform—Reply JAMA (IF 55.0) Pub Date : 2017-09-12 Jonathan Skinner, Kevin G. Volpp
In Reply Dr Colloff correctly points out that moving high-cost patients from private exchanges to Medicare would save money immediately for the federal government, but potentially at the expense of hospitals and physicians. The alternatives currently being debated in Congress to replace the Affordable Care Act, however, would be far worse. With 22 million newly uninsured people seeking health care
-
Medication Reconciliation vs Medication Review JAMA (IF 55.0) Pub Date : 2017-09-12 Kristin M. Zimmerman, Teresa M. Salgado, Dave L. Dixon
To the Editor Dr Rose and colleagues1 proposed that medication reconciliation goes beyond comparing medication lists at admission or discharge and instead comprises the establishment of a correct medication list by completion of 6 levels of reconciliation: clinician agreement, patient agreement, deprescribe, decrease patient burden, minimize out-of-pocket expenses, and inform outside entities.
-
Guideline Recommendations for Statin Therapy—Reply JAMA (IF 55.0) Pub Date : 2017-09-12 Neha J. Pagidipati, Ann Marie Navar, Michael J. Pencina
In Reply We agree with Dr Grossman and colleagues that the size of the discordant population between the USPSTF B recommendation and ACC/AHA class I guideline recommendation will depend on overall guideline adherence and how many lower-risk individuals have an informed conversation with their clinician and decide to initiate statin therapy. We also agree that informed patient-physician discussions
-
Behavioral Economics and Health Insurance Reform JAMA (IF 55.0) Pub Date : 2017-09-12 Edwin Colloff
To the Editor In a Viewpoint, Drs Skinner and Volpp1 discussed principles for health insurance reform drawing on behavioral economics. One principle was to shift high-cost enrollees into Medicare rather than creating new taxes to pay for subsidies. However, there is an unspoken consequence of this recommendation. They pointed out that “inpatient private insurance reimbursements are 75% higher than
-
Guideline Recommendations for Statin Therapy JAMA (IF 55.0) Pub Date : 2017-09-12 David C. Grossman, Susan J. Curry, Douglas K. Owens
To the Editor Dr Pagidipati and colleagues1 compared the US Preventive Services Task Force (USPSTF) recommendations and American College of Cardiology/American Heart Association (ACC/AHA) guidelines on primary prevention of cardiovascular disease (CVD) with statins. We agree that understanding the population effect of these guidelines is important. We wish to emphasize that the USPSTF issued 2 recommendations
-
Association Between Ruptured Distal Biceps Tendon and Wild-Type Transthyretin Cardiac Amyloidosis JAMA (IF 55.0) Pub Date : 2017-09-12 Hallie I. Geller, Avinainder Singh, Kevin M. Alexander, Tara M. Mirto, Rodney H. Falk
-
Antiphospholipid Antibodies JAMA (IF 55.0) Pub Date : 2017-09-12 Arjun Gupta, David H. Johnson, Srikanth Nagalla
-
Acute Diarrheal Infections in Adults JAMA (IF 55.0) Pub Date : 2017-09-12 Mary Acree, Andrew M. Davis
-
Association Between Laparoscopic Antireflux Surgery and Recurrence of Gastroesophageal Reflux JAMA (IF 55.0) Pub Date : 2017-09-12 John Maret-Ouda, Karl Wahlin, Hashem B. El-Serag, Jesper Lagergren
-
Menopausal Hormone Therapy and Long-term All-Cause and Cause-Specific MortalityThe Women’s Health Initiative Randomized Trials JAMA (IF 55.0) Pub Date : 2017-09-12 JoAnn E. Manson, Aaron K. Aragaki, Jacques E. Rossouw, Garnet L. Anderson, Ross L. Prentice, Andrea Z. LaCroix, Rowan T. Chlebowski, Barbara V. Howard, Cynthia A. Thomson, Karen L. Margolis, Cora E. Lewis, Marcia L. Stefanick, Rebecca D. Jackson, Karen C. Johnson, Lisa W. Martin, Sally A. Shumaker, Mark A. Espeland, Jean Wactawski-Wende
-
Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node MetastasisThe ACOSOG Z0011 (Alliance) Randomized Clinical Trial JAMA (IF 55.0) Pub Date : 2017-09-12 Armando E. Giuliano, Karla V. Ballman, Linda McCall, Peter D. Beitsch, Meghan B. Brennan, Pond R. Kelemen, David W. Ollila, Nora M. Hansen, Pat W. Whitworth, Peter W. Blumencranz, A. Marilyn Leitch, Sukamal Saha, Kelly K. Hunt, Monica Morrow
-
The Durability of Antireflux Surgery JAMA (IF 55.0) Pub Date : 2017-09-12 Stuart J. Spechler
Patients who have mild, nonerosive gastroesophageal reflux disease (GERD) have many valid treatment options, but patients with severe erosive GERD (those with endoscopy showing large esophageal mucosal breaks extending between mucosal folds) have only 2: take proton pump inhibitors (PPIs) indefinitely or have antireflux surgery with fundoplication.1 No medication other than PPIs (and potassium-competitive
-
Menopausal Hormone TherapyUnderstanding Long-term Risks and Benefits JAMA (IF 55.0) Pub Date : 2017-09-12 Melissa McNeil
The influence of hormone therapy on the health of women has been a subject of controversy for decades. In the 1960s, when estrogen therapy was first introduced for the treatment of menopausal symptoms, hormones were viewed as a fountain of youth. One of the early hormone advocates, Robert Wilson in his 1966 book about menopause and hormones, stated that “Instead of being condemned to witness the death
-
Breast Cancer SurgeryLess Is More JAMA (IF 55.0) Pub Date : 2017-09-12 Edward H. Livingston, Hsiao Ching Li
Not until the very end of the 19th century did physicians or patients think that breast cancer was curable. Women only presented when the tumors were large and had spread to the axilla and beyond. Attempts to remove these lesions failed and resected cancers recurred so fast it seemed that the surgery fueled their growth. Halstead, operating just before the turn of the 20th century (at Johns Hopkins
-
What Should I Do When I Hear the Call for Medical Assistance in a Plane? JAMA (IF 55.0) Pub Date : 2017-09-12 Gregory L. Eastwood
“If there is a doctor on board, would you please make yourself known to a member of the cabin crew?” Reflexively, my hand shoots up to press the button. Seven times I have responded to such requests. Mostly it has worked out well. Twice I thought the passenger had had too much alcohol. Once I comforted an anxious woman. Another time a young army recruit heading for basic training had unexplained arm
-
-
Mitigating the Mental and Physical Health Consequences of Hurricane Harvey JAMA (IF 55.0) Pub Date : 2017-09-11 James M. Shultz, Sandro Galea
The complexity of the disaster risk landscape and the exposure of large human populations to prolonged and potentially traumatizing events were on full display during Hurricane Harvey. During the 5 days of Hurricane Harvey, more than 33 trillion gallons of rain fell on Texas and Louisiana and set a continental US record for rainfall at 51.88 in (131.78 cm). Among 13 million persons directly affected
-
Association of Trial Registration With Reporting of Primary Outcomes in Protocols and Publications JAMA (IF 55.0) Pub Date : 2017-09-11 An-Wen Chan, Annukka Pello, Jessica Kitchen, Anna Axentiev, Jorma I. Virtanen, Annie Liu, Elina Hemminki
-
Going With the Flow: The Promise and Challenge of Liquid Biopsies JAMA (IF 55.0) Pub Date : 2017-09-08 M.J. Friedrich
-
FDA’s Innovative Plan to Address the Enormous Toll of Smoking JAMA (IF 55.0) Pub Date : 2017-09-08 Kenneth E. Warner, Steven A. Schroeder
On July 28, 2017, US Food and Drug Administration (FDA) Commissioner Scott Gottlieb, MD, announced a comprehensive regulatory plan to expedite reducing the toll of more than 480 000 annual tobacco-related deaths in the United States.1 The plan is predicated on recognition that “nicotine—while highly addictive—is delivered through products that represent a continuum of risk and is most harmful when
-
Targeting Immune Checkpoints in Cancer Therapy JAMA (IF 55.0) Pub Date : 2017-09-08 Suzanne L. Topalian
Drug development in oncology has traditionally focused on therapies that directly target cancer cells—surgery, radiation therapy, chemotherapy, and kinase inhibitors. However, for more than a century it has also been recognized that the immune system interacts with cancer. The immune surveillance hypothesis, proposed in the 1950s, posited that the immune system could recognize and reject cancer cells
-
Research Integrity, Academic Promotion, and Attribution of Authorship and Nonauthor Contributions JAMA (IF 55.0) Pub Date : 2017-09-07 Spyros D. Mentzelopoulos, Spyros G. Zakynthinos
Guidelines for the academic promotion of university faculty members are essential for the achievement and maintenance of high academic quality. However, these guidelines and criteria vary widely around the world and in the United States, with increasing differentiation between faculty focused on careers in investigation vs those who focus on clinical care and teaching. For example, the University of
-
Nutrition Counseling in Clinical PracticeHow Clinicians Can Do Better JAMA (IF 55.0) Pub Date : 2017-09-07 Scott Kahan, JoAnn E. Manson
-
A Century of Progressing and Advancing Reproductive Health CareThe 2017 Lasker-Bloomberg Public Service Award JAMA (IF 55.0) Pub Date : 2017-09-06 Cecile Richards
For 100 years, Planned Parenthood has been leading the effort to expand and protect reproductive health and rights in the United States and has made major contributions to public health during this time. Through innovations in health care delivery and dogged advocacy over the past century, Planned Parenthood has substantially improved health outcomes for women.
-
Preventing Cancer and Other Diseases Caused by Human Papillomavirus Infection2017 Lasker-DeBakey Clinical Research Award JAMA (IF 55.0) Pub Date : 2017-09-06 Douglas R. Lowy, John T. Schiller
The sexually transmitted nature of cervical cancer was recognized by Rigoni-Stern in the 19th century, and human papillomavirus (HPV) infection was known from the early 20th century to cause genital and nongenital warts. However, the medical importance of these viruses was not clearly established until the 1980s with the breakthrough discovery by zur Hausen1 and colleagues that HPV type 16 (HPV-16)
-
JAMA JAMA (IF 55.0) Pub Date : 2017-09-05
The JAMA Network is a consortium of peer-reviewed print and online medical publications that includes JAMA® and 11 other specialty Network journals. JAMA does not hold itself responsible for statements made by any contributor. All articles published, including opinion articles, represent the views of the authors and do not reflect the policy of JAMA, the American Medical Association, or the institution
-
-
“Found: A One Day Cure for Syphilis” JAMA (IF 55.0) Pub Date : 2017-09-05
In the Reader’s Digest for September appears an article by Paul de Kruif entitled “Found: A One Day Cure for Syphilis,” heralded by the editors of that periodical as “the medical sensation of the year.” In this article Mr. de Kruif states that “now there actually is promise of a one day cure.” He asserts without, of course, any basis in fact that “the standard eighteen month course of treatment is
-
-
New Formulation of Lupus Drug JAMA (IF 55.0) Pub Date : 2017-09-05 Rebecca Voelker
A subcutaneous formulation of the human monoclonal antibody belimumab has been approved for adults with active, autoantibody-positive systemic lupus erythematosus (SLE) who receive standard therapy. An intravenous formulation was approved in 2011. Patients will be able to self-administer the medication at home after training from a clinician. Subcutaneous belimumab can be injected once a week from
-
-
Combination Drug for HCV Infection JAMA (IF 55.0) Pub Date : 2017-09-05 Rebecca Voelker
A new 3-drug combination medication for adults with chronic hepatitis C virus (HCV) infection has received FDA approval. The drug is indicated for patients with any of 6 viral genotypes who have either no cirrhosis or only a mild case of the liver disease. Marketed as Vosevi, the drug is a fixed-dose tablet containing 2 previously approved medications—sofosbuvir and velpatasvir—and a new drug, voxilaprevir
-
A Bipartisan “Moonshot” in Health: Improving Care for High-Need Patients JAMA (IF 55.0) Pub Date : 2017-09-05 Dave A. Chokshi
-
Organoids Reveal Clues to Gut-Brain Communication JAMA (IF 55.0) Pub Date : 2017-09-05 Tracy Hampton
-
Managing Conflicts of Interest in Practice Guidelines Panels—Reply JAMA (IF 55.0) Pub Date : 2017-09-05 Harold C. Sox
In Reply It is encouraging to see the growing interest in avoiding COI on practice guidelines panels. The RIGHT checklist is a step in the right direction.1 Ms Morciano and colleagues call for government action to regulate the management of COI in guidelines when guideline producers fail to deal with the problem. This approach may be successful in some countries, and it will be interesting to share
-
Managing Conflicts of Interest in Practice Guidelines Panels JAMA (IF 55.0) Pub Date : 2017-09-05 Cristina Morciano, Carla Faralli, Vittorio Basevi
To the Editor Dr Sox examined the issue of COI in practice guidelines panels.1 He reported that, when available, policies for managing COI performed poorly according to 2 studies2,3 published around the time of the 2011 IOM report.4
-
Managing Conflicts of Interest in Practice Guidelines Panels JAMA (IF 55.0) Pub Date : 2017-09-05 Yaolong Chen, Kehu Yang, Susan L. Norris
To the Editor Dr Sox1 examined conflict of interest (COI) of practice guidelines panels at 2 levels: the individual panel members and the sponsoring organizations. He proposed 4 principles of management of COI that complement the 2011 standards from the Institute of Medicine (IOM; now the National Academy of Medicine).2 The Guidelines International Network also released principles for disclosure of
-
Spinal Manipulative Therapy for Low Back Pain—Reply JAMA (IF 55.0) Pub Date : 2017-09-05 Neil M. Paige, Sally C. Morton, Paul G. Shekelle
In Reply We agree with Dr Lauche and colleagues that in our pooled analysis, the comparison groups were heterogeneous. However, based on published data, we judged them to be far less heterogeneous with respect to their expected effectiveness on pain and function in patients with acute low back pain. The comparison groups included ones that were intended to be ineffective, proven to be ineffective,
-
High-Sensitivity Troponin Levels, Ischemia, and Mortality—Reply JAMA (IF 55.0) Pub Date : 2017-09-05 P. J. Devereaux, Bruce M. Biccard, Matthew T. V. Chan
In Reply Dr Smilowitz points out that some patients who had sepsis or atrial fibrillation and were adjudicated as having a nonischemic etiology as the cause of their elevated hsTnT measurements after noncardiac surgery actually may have had an imbalance in myocardial oxygen supply and demand (ie, an ischemic etiology). We agree with his comment; however, this is often difficult to determine clinically
-
Spinal Manipulative Therapy for Low Back Pain JAMA (IF 55.0) Pub Date : 2017-09-05 Romy Lauche, Tobias Sundberg, Holger Cramer
To the Editor Spinal manipulative therapy (SMT) is very popular; an estimated 19.1 million adults consulted with chiropractors in 2012 in the United States, with spinal pain being the main medical condition for which chiropractic care was sought.1 As such, the systematic review and meta-analysis by Dr Paige and colleagues2 on this topic is important.
-
High-Sensitivity Troponin Levels, Ischemia, and Mortality JAMA (IF 55.0) Pub Date : 2017-09-05 Nathaniel R. Smilowitz
To the Editor In the Vascular Events in Noncardiac Surgery Patients Cohort Evaluation (VISION), postoperative high-sensitivity troponin T (hsTnT) levels were significantly associated with 30-day mortality.1 I question the authors’ decision to exclude some patients with a presumed nonischemic etiology of troponin elevation from their definition of myocardial injury after noncardiac surgery (MINS).
-
Change in Medical Exemptions From Immunization in California After Elimination of Personal Belief Exemptions JAMA (IF 55.0) Pub Date : 2017-09-05 Paul L. Delamater, Timothy F. Leslie, Y. Tony Yang
-
Preimplantation Genetic Diagnosis for Mendelian Conditions JAMA (IF 55.0) Pub Date : 2017-09-05 Siobhan M. Dolan, Tamar H. Goldwaser, Sangita K. Jindal
-
Vision Screening in Children Aged 6 Months to 5 YearsEvidence Report and Systematic Review for the US Preventive Services Task Force JAMA (IF 55.0) Pub Date : 2017-09-05 Daniel E. Jonas, Halle R. Amick, Ina F. Wallace, Cynthia Feltner, Emily B. Vander Schaaf, Callie L. Brown, Claire Baker
-
Vision Screening in Children Aged 6 Months to 5 YearsUS Preventive Services Task Force Recommendation Statement JAMA (IF 55.0) Pub Date : 2017-09-05 David C. Grossman, Susan J. Curry, Douglas K. Owens, Michael J. Barry, Karina W. Davidson, Chyke A. Doubeni, John W. Epling, Alex R. Kemper, Alex H. Krist, Ann E. Kurth, C. Seth Landefeld, Carol M. Mangione, Maureen G. Phipps, Michael Silverstein, Melissa A. Simon, Chien-Wen Tseng
-
Mutation Detection in Patients With Advanced Cancer by Universal Sequencing of Cancer-Related Genes in Tumor and Normal DNA vs Guideline-Based Germline Testing JAMA (IF 55.0) Pub Date : 2017-09-05 Diana Mandelker, Liying Zhang, Yelena Kemel, Zsofia K. Stadler, Vijai Joseph, Ahmet Zehir, Nisha Pradhan, Angela Arnold, Michael F. Walsh, Yirong Li, Anoop R. Balakrishnan, Aijazuddin Syed, Meera Prasad, Khedoudja Nafa, Maria I. Carlo, Karen A. Cadoo, Meg Sheehan, Megan H. Fleischut, Erin Salo-Mullen, Magan Trottier, Steven M. Lipkin, Anne Lincoln, Semanti Mukherjee, Vignesh Ravichandran, Roy Cambria